Jazz Pharmaceuticals Total Non-Operating Income/Expense 2010-2024 | JAZZ
Jazz Pharmaceuticals total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.250B, a 15.72% decline year-over-year.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2023 was $-0.281B, a 8.66% decline from 2022.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2022 was $-0.307B, a 8.53% increase from 2021.
- Jazz Pharmaceuticals annual total non-operating income/expense for 2021 was $-0.283B, a 174.93% increase from 2020.